Αποτελέσματα Αναζήτησης
Diamyd Medical is a Swedish clinical-stage diabetes company active in the field of pharmaceutical development. The share is listed on Nasdaq Stockholm First North (ticker: DMYD B).
- Diabetes
Diamyd Medical is dedicated to finding a way to prevent,...
- Products
The Antigen-specific intralymphatic immunotherapy Diamyd ®....
- Clinical Trials
A Phase II Open Label Study to evaluate the safety and...
- The Company
Diamyd Medical is a Swedish diabetes company active in the...
- Board & Management
Born in 1962. PhD in Biochemistry from Umeå University and...
- Scientific Advisory Board
Diamyd Medical Scientific and Medical Advisory Board....
- Scientific Publications
Intralymphatic GAD-Alum (Diamyd ®) Improves Glycemic Control...
- Events & Mediawatch
Sofia Mayans, who transitioned from her research to...
- Diabetes
14 Νοε 2024 · Diamyd Medical is a Swedish diabetes company active in the field of pharmaceutical development, dedicated to finding a cure for autoimmune diabetes. The share is listed on Nasdaq First North Growth Market (ticker: DMYD B)
Find the latest Diamyd Medical AB (publ) (DMYD-B.ST) stock quote, history, news and other vital information to help you with your stock trading and investing.
Diamyd Medical is headquartered in Stockholm, Kungsgatan 29, Sweden, and has 2 office locations.
Company profile page for Diamyd Inc including stock price, company news, executives, board members, and contact information
Linnégatan 89 B, SE-115 23 Stockholm, Sweden. Tel: +46 8 661 00 26, fax: +46 8 661 63 68 or E-mail: info@diamyd.com. VATno: SE556530-142001.
View Diamyd Medical (www.diamyd.com) location in Stockholm, Sweden , revenue, industry and description. Find related and similar companies as well as employees by title and much more.
